Early detection opportunity Medibio focuses on objective measures for early detection and screening of mental health conditions, presenting a sales opportunity to healthcare providers seeking scalable diagnostic tools and to corporates aiming to improve employee well-being with measurable outcomes.

Corporate wellness angle Their Corporate Health product targets workplace well-being, suggesting upsell potential to large and mid-market employers looking to mitigate productivity risks and healthcare costs through integrated mental health solutions.

Global reach potential With offices in Melbourne and Minneapolis and a development roadmap spanning apps and biometrics, there is potential to partner with US-based healthcare providers, insurers, and multinational employers seeking cross-border mental health tech deployments.

Mobile and biometrics Recent app launches and biometric stress tools indicate a strong user-facing product line; sales efforts can emphasize mobile accessibility, data-driven insights, and clinician-friendly integrations to drive adoption in both consumer and provider markets.

Funding and expansion signals Despite a small revenue base, substantial funding and leadership changes signal growth intent; target opportunities include strategic partnerships, contracted pilots, and grant-enabled programs with health systems and corporate accounts to scale revenue.